| Literature DB >> 15831382 |
Eva Stoger1, Julian K-C Ma, Rainer Fischer, Paul Christou.
Abstract
Among the many plant-based production systems that have been developed for pharmaceutical proteins, seeds have the useful advantage of accumulating proteins in a relatively small volume and in a stable environment in which they are protected from degradation. Several seed crops, including cereals, grain legumes and oilseeds, have been explored as production platforms, and the first commercial products -- all technical proteins and enzymes -- have already reached the market. Recent studies have explored the use of seeds for the production of pharmaceutical proteins, particularly replacement human proteins, recombinant antibodies and (oral) vaccines.Entities:
Mesh:
Substances:
Year: 2005 PMID: 15831382 DOI: 10.1016/j.copbio.2005.01.005
Source DB: PubMed Journal: Curr Opin Biotechnol ISSN: 0958-1669 Impact factor: 9.740